Agency | Centers for Disease Control and Prevention |
---|---|
Market | Unvaccinated Americans |
Language | English |
Product |
|
Release date(s) | 1962 |
Produced by | Harold M. Walker |
Country | United States |
Wellbee was an American cartoon character and public health mascot that first appeared in 1962. He was an anthropomorphic bumblebee created by Hollywood artist Harold M. Walker at the request of Centers for Disease Control and Prevention's (CDC) public information officer George M. Stenhouse. The character became CDC's national symbol of public health at the time, and was widely used to promote immunization and other public health campaigns in the United States following the Vaccination Assistance Act of 1962.
Wellbee, a standing cartoon character bumblebee with a smiling round face representing "well-being", was created by the Hollywood artist Harold M. Walker, at the request of CDC's public information officer George M. Stenhouse. [1] [2] Referred to by the CDC as "he", Wellbee was first revealed in The Atlanta Journal-Constitution newspaper on March 11, 1962, following a press release that described the character as "a pleasant-faced, bright–eyed, happy cartoon character, who is the personification of good health." [1]
The purpose of the character was the promotion of preventive health measures and the importance of vaccination. [2] At the time, the US government had substantially increased funding and new programs in public health, and with the support of the Vaccination Assistance Act of 1962, sponsored the CDC in its educational efforts, the symbol of which became Wellbee. [2] [3]
The marketing campaign by the CDC planned appearances of Wellbee at public health events and in leaflets, newspapers and posters, and on radio and television, beginning with promoting Sabin's oral polio vaccine in Atlanta and across the United States. [1] [4] Local health departments used the character Wellbee. [2] In Atlanta and Tampa, a smiling Wellbee appeared on posters encouraging children to "drink the free polio vaccine", stating it "tastes good, works fast, prevents polio". [2] In Chicago, its image appeared on pin-back buttons and billboards. [2] A person dressed as Wellbee posed with baseball players Bill Monbouquette, Dick Radatz and Eddie Bressoud of the Boston Red Sox at Fenway Park. [5] Also in Boston, Wellbee stood alongside mayor John F. Collins, who had been affected by polio. [2]
The bee visited schools in Honolulu, appeared on a dog sled in Anchorage, and in Dallas it cautioned against being "Illbee". [2] Subsequent immunization campaigns included promoting vaccines against diphtheria and tetanus, [1] and the character was used to emphasize the benefits of hand-washing, exercise, oral health, and injury prevention, [1] becoming familiar to children and the national symbol of public health. [6] In 1964 posters encouraged the vaccinated to get boosted. [7]
Within a year, Stenhouse noted "Wellbee, the 'health educator's friend', had a busy year. [1] He was particularly active in promoting community polio programs. He spoke Spanish in New Mexico; he came to life in costume in Hawaii and led a parade." [1]
As a result of the Vaccination Assistance Act, 50 million people were vaccinated against polio between 1962 and 1964 and seven million children received the vaccine that prevents diphtheria, tetanus and whooping cough, resulting in a fall in cases of polio and diphtheria. [2] In 1965 the Vaccination Assistance Act was extended. [2]
Several vaccine mascots have been created since Wellbee. [8] According to the director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine, Heidi Larson, vaccine mascots are "humorous, playful", and it "makes it seem less clinical, less government-driven, less 'You have to take this'", thereby engaging young and older groups. [8]
Public health posters featuring Wellbee:
Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a weakened, live or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. Herd immunity protects those who may be immunocompromised and cannot get a vaccine because even a weakened version would harm them. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio and tetanus from much of the world. According to the World Health Organization (WHO), vaccination prevents 3.5–5 million deaths per year. A WHO-funded study by The Lancet estimates that, during the 50-year period starting in 1974, vaccination prevented 154 million deaths, including 146 million among children under age 5. However, some diseases have seen rising cases due to relatively low vaccination rates attributable partly to vaccine hesitancy.
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and recognize further and destroy any of the microorganisms associated with that agent that it may encounter in the future.
Diphtheria is an infection caused by the bacterium Corynebacterium diphtheriae. Most infections are asymptomatic or have a mild clinical course, but in some outbreaks, the mortality rate approaches 10%. Signs and symptoms may vary from mild to severe, and usually start two to five days after exposure. Symptoms often develop gradually, beginning with a sore throat and fever. In severe cases, a grey or white patch develops in the throat, which can block the airway, and create a barking cough similar to what is observed in croup. The neck may also swell, in part due to the enlargement of the facial lymph nodes. Diphtheria can also involve the skin, eyes, or genitals, and can cause complications, including myocarditis, inflammation of nerves, kidney problems, and bleeding problems due to low levels of platelets.
Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization (WHO) recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 33 in 2018.
The DPT vaccine or DTP vaccine is a class of combination vaccines to protect against three infectious diseases in humans: diphtheria, pertussis, and tetanus (lockjaw). The vaccine components include diphtheria and tetanus toxoids, and either killed whole cells of the bacterium that causes pertussis or pertussis antigens. The term toxoid refers to vaccines which use an inactivated toxin produced by the pathogen which they are targeted against to generate an immune response. In this way, the toxoid vaccine generates an immune response which is targeted against the toxin which is produced by the pathogen and causes disease, rather than a vaccine which is targeted against the pathogen itself. The whole cells or antigens will be depicted as either "DTwP" or "DTaP", where the lower-case "w" indicates whole-cell inactivated pertussis and the lower-case "a" stands for "acellular". In comparison to alternative vaccine types, such as live attenuated vaccines, the DTP vaccine does not contain any live pathogen, but rather uses inactivated toxoid to generate an immune response; therefore, there is not a risk of use in populations that are immune compromised since there is not any known risk of causing the disease itself. As a result, the DTP vaccine is considered a safe vaccine to use in anyone and it generates a much more targeted immune response specific for the pathogen of interest.
A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease, in order to prevent or reduce the effects of infection by any natural or "wild" pathogen. Vaccines go through multiple phases of trials to ensure safety and effectiveness.
In immunology, passive immunity is the transfer of active humoral immunity of ready-made antibodies. Passive immunity can occur naturally, when maternal antibodies are transferred to the fetus through the placenta, and it can also be induced artificially, when high levels of antibodies specific to a pathogen or toxin are transferred to non-immune persons through blood products that contain antibodies, such as in immunoglobulin therapy or antiserum therapy. Passive immunization is used when there is a high risk of infection and insufficient time for the body to develop its own immune response, or to reduce the symptoms of ongoing or immunosuppressive diseases. Passive immunization can be provided when people cannot synthesize antibodies, and when they have been exposed to a disease that they do not have immunity against.
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people, routine immunization results in more than 95% of people being protected.
A vaccination policy is a health policy adopted in order to prevent the spread of infectious disease. These policies are generally put into place by state or local governments, but may also be set by private facilities, such as workplaces or schools. Many policies have been developed and implemented since vaccines were first made widely available.
Vaccinate Your Family (VYF), formerly known as Every Child By Two (ECBT), is a non-profit organization, based in the United States, which advocates for vaccinations. Founded in 1991, its stated goals are to "raise awareness of the critical need for timely immunizations and to foster a systematic way to immunize all of America's children by age two." ECBT was founded by former First Lady of the United States Rosalynn Carter and former First Lady of Arkansas Betty Bumpers. ECBT was renamed to Vaccinate Your Family in 2018.
Diphtheria vaccine is a toxoid vaccine against diphtheria, an illness caused by Corynebacterium diphtheriae. Its use has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000. The first dose is recommended at six weeks of age with two additional doses four weeks apart, after which it is about 95% effective during childhood. Three further doses are recommended during childhood. It is unclear if further doses later in life are needed.
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis). There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. The effectiveness of the vaccines appears to decrease by between 2 and 10% per year after vaccination with a more rapid decrease with the acellular vaccines. The vaccine is only available in combination with tetanus and diphtheria vaccines. Pertussis vaccine is estimated to have saved over 500,000 lives in 2002.
Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When the rate of vaccination within a population is greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if the rate of vaccination decreases. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days after exposure to measles.
Life expectancy in France at birth was 81 years in 2008. A new measure of expected human capital calculated for 195 countries from 1990 to 2016 and defined for each birth cohort as the expected years lived from age 20 to 64 years and adjusted for educational attainment, learning or education quality, and functional health status was published by the Lancet in September 2018. France had the ninth highest level of expected human capital with 25 health, education, and learning-adjusted expected years lived between age 20 and 64 years.
A Vaccine Information Statement (VIS) is a document designed by the Centers for Disease Control and Prevention (CDC) to provide information to a patient receiving a vaccine in the United States. The National Childhood Vaccine Injury Act requires that medical professionals provide a VIS to patients before receiving certain vaccinations. The VIS includes information about the vaccine's benefits and risks, a description of the vaccine, indications and contraindications, instructions for patients experiencing an adverse reaction, and additional resources.
Tetanus vaccine, also known as tetanus toxoid (TT), is a toxoid vaccine used to prevent tetanus. During childhood, five doses are recommended, with a sixth given during adolescence.
World Immunization Week is a global public health campaign to raise awareness and increase rates of immunization against vaccine-preventable diseases around the world. It takes place each year during the last week of April.
DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B.
A speculated link between vaccines and SIDS has been refuted, but remains a common anti-vaccine claim. The claim, attributed to Robert Mendelsohn in 1991 and promoted by anti-vaccination activists such as Viera Scheibner in the early 1990s, is that vaccines, especially the DTP vaccine that protects against diphtheria, tetanus and pertussis, sometimes causes sudden infant death syndrome. The World Health Organization has classified this as a "common misconception".
Zé Gotinha is a Brazilian mascot created to promote vaccination campaigns against the polio virus with the goal of making the event more attractive to children. It was used in campaigns in the 1980s, 1990s, and 2006 campaigns to raise awareness among parents and children about the importance of vaccination. Zé Gotinha has also been used to warn about the importance of preventing various other diseases.